Nabiha Saklayen is the CEO and co-founder of Cellino, where she is dedicated to building an autonomous factory for cellular reprogramming. Her work at Cellino focuses on personalized medicine, aiming to repair, restore, and enable individuals to thrive using their own cells. She notes the conditional approval of the first iPSC-derived therapies in Japan, highlighting the need for infrastructure to advance human regeneration.